20 / 85
Adverse events of special interest
Presented By Karim Fizazi at 2017 ASCO Annual Meeting
Clasificaci
ó
n, estructura, mecanismo de acci
ó
n, dosis, contraindicaciones y forma de administraci
ó
n de los f
á
rmacos inmunoter
á
picos en carcinoma urotelial